Showing results (441-450 of 4,510) with videos related to

Sort By:
Pageof 451
Future Oncology (London, England)|July 11, 2018
Tubular carcinomas of the breast: an epidemiologic studyJia-Yuan Sun, Juan Zhou, Wen-Wen Zhang, et al.
Future Oncology (London, England)|July 11, 2018
Emerging targets in advanced non-small-cell lung cancerFrancesco Valentino, Gloria Borra, Paolo Allione, et al.
Future Oncology (London, England)|July 13, 2018
The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopeciaMollie M Mustoe, Carmen M Lee, Michelle E Melisko, et al.
Future Oncology (London, England)|June 6, 2018
Aldoxorubicin therapy for the treatment of patients with advanced soft tissue sarcomaMahesh Seetharam, Kantha R Kolla, Kristen N Ganjoo
Future Oncology (London, England)|June 6, 2018
A head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemiaConstantine S Tam, Veronique LeBlond, William Novotny, et al.
Future Oncology (London, England)|September 22, 2016
Novel insights and therapeutic interventions for pediatric osteosarcomaLeo Kager, Gevorg Tamamyan, Stefan Bielack
Future Oncology (London, England)|September 1, 2016
Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumorsGiuseppe Aprile, Mariaelena Casagrande, Giovanna De Maglio, et al.
Future Oncology (London, England)|May 12, 2017
Venetoclax for the treatment of patients with chronic lymphocytic leukemiaJennifer Crombie, Matthew S Davids
Future Oncology (London, England)|May 9, 2017
Eribulin across multiple lines of chemotherapy: a retrospective study on quality of life and efficacy in metastatic breast cancer patientsErica Quaquarini, Federico Sottotetti, Daniela D'Ambrosio, et al.
Future Oncology (London, England)|May 9, 2017
Eribulin rapidly reduces the aggressiveness of second primary breast cancer: a case reportIsacco Falco, Silvia Stragliotto
Pageof 451